July 27, 2021 23:56 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Javed Akhtar defamation: Mumbai court gives 'last chance' to Kangana Ranaut, asks her to attend next hearing | Ex-CBI special director Rakesh Asthana appointed Delhi Police Commissioner | US Secretary of State Antony Blinken arrives in India, to hold talks with leaders tomorrow | BJP picks up Basavaraj Bommai as new CM for Karnataka, Yediyurappa congratulates his successor | Tokyo Olympics 2020: Indian shooters disappoint, make early exits

After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin

New Delhi/IBNS:  After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.